0000899243-17-012052.txt : 20170505 0000899243-17-012052.hdr.sgml : 20170505 20170505213413 ACCESSION NUMBER: 0000899243-17-012052 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170427 FILED AS OF DATE: 20170505 DATE AS OF CHANGE: 20170505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 8585520866 MAIL ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lowrance David L CENTRAL INDEX KEY: 0001408498 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 17820086 MAIL ADDRESS: STREET 1: 422 WILLIAM WALLACE DRIVE CITY: FRANKLIN STATE: TN ZIP: 37064 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2017-04-27 0 0001160308 Savara Inc SVRA 0001408498 Lowrance David L 900 S. CAPITAL OF TEXAS HIGHWAY, SUITE 150 AUSTIN TX 78746 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.51 2026-10-25 Common Stock 127578 D The shares subject to the option vest and become exercisable in sixteen equal quarterly installments beginning on February 1, 2017. /s/ David L. Lowrance 2017-05-05